Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2014, Article ID 309378, 10 pages
http://dx.doi.org/10.1155/2014/309378
Research Article

Anti-Inflammatory Effects of the Chinese Herbal Formula Sini Tang in Myocardial Infarction Rats

1Center of Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences, No. 1 Xiyuan Caochang, Haidian District, Beijing 100091, China
2Molecular Research in Traditional Chinese Medicine Group, Department of Pathophysiology and Allergy Research, Vienna General Hospital, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria
3Department of Pharmacognosy, Institute of Pharmaceutical Sciences, University of Graz, Universitaetsplatz 4/I, 8010 Graz, Austria
4Clinical Division of Cardiology, Department of Internal Medicine II, Vienna General Hospital, Medical University of Vienna, Waehringer Guertel 18-20, 1090 Vienna, Austria

Received 3 November 2013; Revised 24 January 2014; Accepted 27 January 2014; Published 3 March 2014

Academic Editor: Joen-Rong Sheu

Copyright © 2014 Jiangang Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. López-Sendón, “The heart failure epidemic,” Medicographia, vol. 33, pp. 363–369, 2011. View at Google Scholar
  2. P. G. Steg, S. K. James, D. Atar, L. P. Badano, and C. Blomstrom-Lundqvist, “ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation,” European Heart Journal, vol. 33, pp. 2569–2619, 2012. View at Google Scholar
  3. N. G. Frangogiannisa, C. W. Smithb, and L. M. Entmana, “The inflammatory response in myocardial infarction,” Cardiovascular Research, vol. 53, pp. 31–47, 2002. View at Google Scholar
  4. J. L. Mehta and D. Y. Li, “Inflammation in ischemic heart disease: response to tissue injury or a pathogenetic villain?” Cardiovascular Research, vol. 43, no. 2, pp. 291–299, 1999. View at Publisher · View at Google Scholar · View at Scopus
  5. I. Morishima, T. Sone, H. Tsuboi et al., “Plasma C-reactive protein predicts left ventricular remodeling and function after a first acute anterior wall myocardial infarction treated with coronary angioplasty: comparison with brain natriuretic peptide,” Clinical Cardiology, vol. 25, no. 3, pp. 112–116, 2002. View at Google Scholar · View at Scopus
  6. G. Berton, R. Cordiano, R. Palmieri, S. Pianca, V. Pagliara, and P. Palatini, “C-reactive protein in acute myocardial infarction: association with heart failure,” American Heart Journal, vol. 145, no. 6, pp. 1094–1101, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Nian, P. Lee, N. Khaper, and P. Liu, “Inflammatory cytokines and postmyocardial infarction remodeling,” Circulation Research, vol. 94, no. 12, pp. 1543–1553, 2004. View at Publisher · View at Google Scholar · View at Scopus
  8. J. Tian, “Observation of treatment on 105 acute myocardial infarction patients using Si Ni Tang,” Tian Jin Medical Reports, vol. 11, pp. 16–20, 1972. View at Google Scholar
  9. G. Li, W. Qi, and K. Xiong, “Clinical observation on 51 patients of acute myocardial infarction treated with thrombolytic therapy combined with Chinese herbal medicine,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 19, no. 8, pp. 461–462, 1999. View at Google Scholar · View at Scopus
  10. Z.-T. Wang, S.-R. Wang, and M.-J. Zhao, “Comparative study on effect of recipe for activating blood circulation and replenishing Qi on left ventricular remodeling in rats with left heart failure after myocardial infarction,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 22, no. 5, pp. 376–378, 2002. View at Google Scholar · View at Scopus
  11. Z. He, Y. Wu, M.-X. Jiang, R.-Q. Cheng, and R. Shen, “Observation by color doppler ultrasound on endothelium-dependent dilation of congestive heart failure treated with Kanli Decoction,” Journal of Chinese Integrative Medicine, vol. 2, no. 4, pp. 268–270, 2004. View at Google Scholar · View at Scopus
  12. Y. F. Li, F. F. Cao, F. Liu, X. Y. Bai, and Y. Lu, “Effects of Shexiangbaoxin pills on the expression of cardiac alpha (1)- and beta-adrenergic receptor subtypes in rat hearts with heart failure induced by myocardial infarction,” Chinese Medical Journal, vol. 125, pp. 1556–1562, 2012. View at Google Scholar
  13. J. Luo and H. Xu, “Outcome measures of chinese herbal medicine for coronary heart disease: an overview of systematic reviews,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 927392, 9 pages, 2012. View at Publisher · View at Google Scholar
  14. Z. Zhang, Shang Han Lun (Discussion of Cold-Induced Disorders), Public Health Press, 2005.
  15. W. Dietl, K. Trescher, P. Hohensinner et al., “SiNiTang—a traditional Chinese herbal remedy improves cardiac function post-MI,” Journal of Clinical & Experimental Cardiology, vol. 5, pp. 1–4, 2012. View at Google Scholar
  16. K. Peter K, J. Schinnerl, S. Felsinger et al., “A novel concept for detoxification: complexation between aconitine and liquiritin in a Chinese herbal formula (“Sini Tang”),” Journal of Ethnopharmacology, vol. 149, pp. 562–569, 2013. View at Google Scholar
  17. J. H. Boyd, S. Mathur, Y. Wang, R. M. Bateman, and K. R. Walley, “Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-κB dependent inflammatory response,” Cardiovascular Research, vol. 72, no. 3, pp. 384–393, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. F. Arslan, M. B. Smeets, L. A. J. O'Neill et al., “Myocardial ischemia/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody,” Circulation, vol. 121, no. 1, pp. 80–90, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. J. Favre, P. Musette, V. Douin-Echinard et al., “Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 5, pp. 1064–1071, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. J.-I. Oyama, C. Blais Jr., X. Liu et al., “Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice,” Circulation, vol. 109, no. 6, pp. 784–789, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Llorens, J. Jordán, and E. Nava, “The nitric oxide pathway in the cardiovascular system,” Journal of Physiology and Biochemistry, vol. 58, no. 3, pp. 179–188, 2002. View at Google Scholar · View at Scopus
  22. J. E. Toblli, F. DiGennaro, J. F. Giani, and F. P. Dominici, “Nebivolol: impact on cardiac and endothelial function and clinical utility,” Vascular Health and Risk Management, vol. 8, pp. 151–160, 2012. View at Google Scholar
  23. B. Boyer, K. W. Hart, M. I. Sperling, C. J. Lindsell, and S. P. Collins, “Biomarker changes during acute heart failure treatment,” Congestive Heart Failure, vol. 18, no. 2, pp. 91–97, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. J. R. Dietz, “Mechanisms of atrial natriuretic peptide secretion from the atrium,” Cardiovascular Research, vol. 68, no. 1, pp. 8–17, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. V. Cannone, B. K. Huntley, T. M. Olson et al., “Atrial natriuretic peptide genetic variant rs5065 and risk for cardiovascular disease in the general community: a 9-year follow-up study,” Hypertension, vol. 62, no. 5, pp. 860–865, 2013. View at Google Scholar
  26. H. K. Gaggin, L. James, and J. L. Januzzi Jr., “Biomarkers and diagnostics in heart failure,” Biochimica et Biophysica Acta, vol. 1832, no. 12, pp. 2442–2450, 2013. View at Google Scholar
  27. T. M. Kolettis, M. Barton, D. Langleben, and Y. Matsumura, “Endothelin in coronary artery disease and myocardial infarction,” Cardiology in Review, vol. 21, no. 5, pp. 249–256, 2013. View at Google Scholar
  28. C. Borghi, P. Marino, P. Zardini, B. Magnani, S. Collatina, and E. Ambrosioni, “Short- and long-term effects of early fosinopril administration in patients with acute anterior myocardial infarction undergoing intravenous thrombolysis: results from the Fosinopril in Acute Myocardial Infarction Study,” American Heart Journal, vol. 136, no. 2, pp. 213–225, 1998. View at Google Scholar · View at Scopus
  29. D. P. Bicket, “Using ACE inhibitors appropriately,” American Family Physician, vol. 66, no. 3, pp. 461–473, 2002. View at Google Scholar · View at Scopus
  30. A. E. Berezin, “Effect of fosinopril on the rate of neurohumoral and proinflammatory activation in patients with heart failure,” Klinicheskaia Meditsina, vol. 82, no. 9, pp. 29–32, 2004. View at Google Scholar · View at Scopus
  31. I. Resources, Guide for the Care and Use of Laboratory Animals, Commission on Life Sciences, National Research Council. National Academy Press, Washington, DC, USA, 1996.
  32. D. Csupor, E. M. Wenzig, I. Zupkó, K. Wölkart, J. Hohmann, and R. Bauer, “Qualitative and quantitative analysis of aconitine-type and lipo-alkaloids of Aconitum carmichaelii roots,” Journal of Chromatography A, vol. 1216, no. 11, pp. 2079–2086, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. J. M. Pfeffer, M. A. Pfeffer, P. J. Fletcher, and E. Braunwald, “Ventricular performance in rats with myocardial infarction and failure,” American Journal of Medicine, vol. 76, pp. 99–103, 1984. View at Google Scholar · View at Scopus
  34. H.-J. Yin, Y. Zhang, and Y.-R. Jiang, “Effect of folium panax quinquefolium saponins on apoptosis of cardiac muscle cells and apoptosis-related gene expression in rats with acute myocardial infarction,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 25, no. 3, pp. 232–235, 2005. View at Google Scholar · View at Scopus
  35. H.-J. Yin, Y. Zhang, and Y.-R. Jiang, “Effect of folium panax quinquefolium saponins on apoptosis of cardiac muscle cells and apoptosis-related gene expression in rats with acute myocardial infarction,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 25, no. 3, pp. 232–235, 2005. View at Google Scholar · View at Scopus
  36. M. J. Koren, R. B. Devereux, P. N. Casale, D. D. Savage, and J. H. Laragh, “Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension,” Annals of Internal Medicine, vol. 114, no. 5, pp. 345–352, 1991. View at Google Scholar · View at Scopus
  37. A.-M. Wu, M.-J. Zhao, and D.-M. Zhang, “Characteristics of TCM syndrome and appraisal with echocardiography in heart failure rats after myocardial infarction,” Chinese Journal of Integrated Traditional and Western Medicine, vol. 27, no. 3, pp. 227–230, 2007. View at Google Scholar · View at Scopus
  38. J. Takagawa, Y. Zhang, M. L. Wong et al., “Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area- and length-based approaches,” Journal of Applied Physiology, vol. 102, no. 6, pp. 2104–2111, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Panteghini, “Role and importance of biochemical markers in clinical cardiology,” European Heart Journal, vol. 25, no. 14, pp. 1187–1196, 2004. View at Publisher · View at Google Scholar · View at Scopus
  40. Y. Sato, H. Fujiwara, and Y. Takatsu, “Biochemical markers in heart failure,” Journal of Cardiology, vol. 59, no. 1, pp. 1–7, 2012. View at Publisher · View at Google Scholar · View at Scopus
  41. V. C. Chung, M. Chen, Q. Ying et al., “Add-on effect of chinese herbal medicine on mortality in myocardial infarction: systematic review and meta-analysis of randomized controlled trials,” Evidence-Based Complementary and Alternative Medicine, vol. 2013, Article ID 675906, 12 pages, 2013. View at Publisher · View at Google Scholar
  42. A. Evangelista, F. Flachskampf, P. Lancellotti et al., “European Association of Echocardiography recommendations for standardization of performance, digital storage and reporting of echocardiographic studies,” European Journal of Echocardiography, vol. 9, no. 4, pp. 438–448, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. X. Yang, Z. Chong, and Y. Guo, “The regulating effects of Sinitang on vasoactive substance in rats with renal hypertension,” Chinese Journal of Clinical Pharmacy, vol. 28, 2008. View at Google Scholar
  44. S. R. Kapadia, H. Oral, J. Lee, M. Nakano, G. E. Taffet, and D. L. Mann, “Hemodynamic regulation of tumor necrosis factor-α gene and protein expression in adult feline myocardium,” Circulation Research, vol. 81, no. 2, pp. 187–195, 1997. View at Google Scholar · View at Scopus
  45. Q. Fan, “Science of prescriptions,” in A Newly Compiled Practical English-Chinese Library of Traditional Chinese Medicine, pp. 94–96, Publishing House of Shanghai University of Traditional Chinese Medicine, 2002. View at Google Scholar
  46. R. C. Lantz, G. J. Chen, M. Sarihan, A. M. Sólyom, S. D. Jolad, and B. N. Timmermann, “The effect of extracts from ginger rhizome on inflammatory mediator production,” Phytomedicine, vol. 14, no. 2-3, pp. 123–128, 2007. View at Publisher · View at Google Scholar · View at Scopus
  47. H. Ueda, K. Ippoushi, and A. Takeuchi, “Repeated oral administration of a squeezed ginger (Zingiber officinale) extract augmented the serum corticosterone level and had anti-inflammatory properties,” Bioscience, Biotechnology and Biochemistry, vol. 74, no. 11, pp. 2248–2252, 2010. View at Publisher · View at Google Scholar · View at Scopus
  48. J. S. Hwa, Y. C. Jin, Y. S. Lee et al., “2-methoxycinnamaldehyde from Cinnamomum cassia reduces rat myocardial ischemia and reperfusion injury in vivo due to HO-1 induction,” Journal of Ethnopharmacology, vol. 139, no. 2, pp. 605–615, 2012. View at Publisher · View at Google Scholar · View at Scopus
  49. L. Siracusa, A. Saija, M. Cristani et al., “Phytocomplexes from liquorice (Glycyrrhiza glabra L.) leaves—chemical characterization and evaluation of their antioxidant, anti-genotoxic and anti-inflammatory activity,” Fitoterapia, vol. 82, no. 4, pp. 546–556, 2011. View at Publisher · View at Google Scholar · View at Scopus
  50. S.-W. Kim, Y. Jin, J.-H. Shin et al., “Glycyrrhizic acid affords robust neuroprotection in the postischemic brain via anti-inflammatory effect by inhibiting HMGB1 phosphorylation and secretion,” Neurobiology of Disease, vol. 46, no. 1, pp. 147–156, 2012. View at Publisher · View at Google Scholar · View at Scopus